Press release
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of offerings.
The digitization of data and advances in information processing, have led to the development of a wide array of tools and analytical algorithms that can now be used to mine pharmaceutical big data. The insights generated from such studies are increasingly being used to drive important judgements concerning pharmacology and healthcare. Presently, big pharmaceutical companies are estimated to spend nearly USD 20 million on an annual basis, on the generation of real world evidence to support their respective product development programs.
To order this 350+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/pharmaceutical-real-world-evidence-market/261.html
Key Market Insights
Over 240 companies claim to offer real world evidence-related services for various applications
More than 45% of these companies are start-ups / small sized players (with less than 50 employees). It is also worth highlighting that 27% of the stakeholders in this market claim to use patient powered data; the second most popular source of real world data that is used by 26% of service providers is clinical setting data.
More than 90% of the companies involved in this upcoming field of research, are based in the developed regions
Within North America, most of the real world evidence focused companies are headquartered in the US. Considering its technological superiority and the fact that it is generally open to accepting new paradigms, the US market is presently considered a hub for real world data research. In Europe, companies that claim to specialize in real world evidence are distributed across the UK, France, Ireland, and Switzerland.
Over 100 global events related to real world evidence were organized in the past couple of years
Among the active industry players, Pfizer participated in most of these events (70), followed by Merck, Janssen, Sanofi, Amgen, Eli Lilly, GSK and AstraZeneca. These events featured the participation of several non-industry players as well, which includes US FDA, University of California, Harvard Medical School and Stanford University.
Close to 2,200 articles on real world evidence have been published in reputed scientific journals since 2016
More than 20% of the publications mentioned in the report, were focused on generating / using real word evidence-based insights for the assessment of treatment safety / effectiveness of various medical products. Popular journals, in terms of number of real-world evidence-related articles published, include Pharmacoepidemiology and Drug Safety, The New England Journal of Medicine, Diabetes Therapy, and Diabetes, Obesity and Metabolism.
In the last 10 years, close to 1,600 clinical trials informed using real world evidence have been registered
The number of such trials, that have been registered in the recent past, have increased at a CAGR of 21% from 2010 to 2019. Majority of these trials are focused on cardiovascular disorders, oncological disorders and neurological disorders. Amidst the COVID-19 pandemic, several trials focused on the novel coronavirus related condition have been informed using real world data.
North America and Europe are anticipated to capture over 65% of the market share by 2030
Based on the analysis in the report, the North American real world evidence market is estimated to grow at the fastest pace (around 16% annualized growth), in terms of service revenues. Further, it is worth mentioning that the real world evidence services market in the Latin America is anticipated to grow annually at 15.5%, followed by Middle East and North Africa (12.7%).
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/228/request-sample.html
Key Questions Answered
Who are the leading players offering real world evidence-related services?
What is the current regulatory framework related to generation of real world data across various geographies?
What are the key drivers of acquisition activity within the real world evidence market?
Where in the world are clinical trial informed using real world evidence, being conducted?
How has the COVID-19 pandemic impacted the real world evidence market?
What is the cost saving potential associated with the use of real world evidence in drug discovery research?
How is the current and future opportunity likely to be distributed across key market segments?
The USD 4.5 billion (by 2030) financial opportunity within the real world evidence market has been analyzed across the following segments:
Type of Application
Early Stage Research
Clinical Development
Regulatory Approval, Pricing / Reimbursement
Post-Approval Studies
Types of Real World Data Sources
Medical Claims
Clinical Trials
Clinical Setting
Patient Powered
Other Data Sources
Therapeutic Area
Autoimmune Disorders
Cardiovascular Disorders
Infectious Diseases
Metabolic Disorders
Neurological / Psychiatric Disorders
Oncological Disorders
Respiratory Disorders
Other Disorders
Geography
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Rest of the World
The report features inputs from eminent industry stakeholders, according to whom the use of real world evidence has the potential to reduce drug approval timelines by about five years, and the associated capital investment in R&D, by 50-60%. The report includes detailed transcripts of the discussions held with the following industry experts:
Limor BH Epstein (Founder, Data2Life)
Fernando Santa (Chief Operating Officer, Adarna Health Data)
Jonathan Moshinsky (Chief Strategy Officer, uMotif)
Anonymous (Vice President, A Big Pharmaceutical Company)
Wirth Peter (Vice President, RTI Health Solutions)
Douglas Drake (Senior Director, Clinerion)
Jane Reed (Director, Life Sciences, Linguamatics)
Anonymous (Savana)
The research includes profiles of some of the key players (listed below) in this filed, each profile features an overview of the company, information related to its real world evidence-related technologies / platforms / services portfolio, recent developments and an informed future outlook.
Clinerion
Clinigen Group
Cognizant Analytics
Evidera
HealthCore
IBM Watson Health (IBM)
ICON
IQVIA
Medpace
NorthWest EHealth
OptumInsight
Oracle
PAREXEL
PerkinElmer
SAS
Syneos Health
TriNetX
For additional details, please visit https://www.rootsanalysis.com/reports/view_document/pharmaceutical-real-world-evidence-market/261.html
You may also be interested in the following titles:
1. Drug Repurposing Service Providers Market, 2020-2030
2. Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030
3. Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030: Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive) and Purpose of Solution (Medication Replacement and Medication Augmentation)
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis here
News-ID: 2251205 • Views: …
More Releases from Roots Analysis
Autoinjectors Market to Reach USD 299 Billion by 2035 at 5.7% CAGR | SHL Medical …
The global autoinjectors market, valued at USD 170 billion in 2025, will reach USD 181 billion in 2026 and climb to USD 299 billion by 2035, advancing at a CAGR of 5.7% over the forecast period. The growth reflects accelerating demand for self-administration devices across chronic disease management, a wave of biosimilar launches entering autoinjector formats, and a measurable shift in patient care from clinical settings to home environments.
To access…
Antiviral Drugs Market to Reach USD 127 Billion by 2035, Growing at 6.1% CAGR | …
The global antiviral drugs market, valued at USD 69 billion in 2025, will reach USD 74 billion in 2026 and climb to USD 127 billion by 2035, advancing at a CAGR of 6.1% over the forecast period. Infectious disease burden, accelerating R&D pipelines, and the post-pandemic push for novel antivirals are collectively reshaping this market into one of the pharmaceutical sector's most active growth categories.
To explore the complete findings, request…
Antibody Drug Conjugate (ADC) Market to Reach $28.41 Billion by 2035 | AstraZene …
The global antibody drug conjugate (ADC) market, valued at USD 15.29 billion in 2025, will grow to USD 18.69 billion in 2026 and reach USD 28.41 billion by 2035, advancing at a CAGR of 4.8% through the forecast period. With 19 approved therapies already on the market and an active clinical pipeline spanning hundreds of programs, the ADC sector has moved well past proof-of-concept and into a sustained commercial expansion…
Antibody Discovery Services and Platforms Market to Reach $6.3 Billion by 2035 a …
The global antibody discovery market, valued at $2.0 billion in 2025, will climb to $2.2 billion in 2026 and reach $6.3 billion by 2035, compounding at a CAGR of 12.3% over the forecast period. Surging demand for targeted biologics, a record pace of monoclonal antibody approvals, and the accelerating adoption of AI-assisted discovery platforms are converging to make this one of the most commercially consequential segments in the life sciences…
More Releases for North
Mind & Body Support Expands Personalised Disability Services Across Melbourne's …
ELTHAM, VIC - Mind & Body Support, a Melbourne-based provider of disability support services [https://mindandbodysupport.com.au/], is continuing to grow its reach across the city's northern and north-eastern suburbs, offering personalised, goal-based support to children, teenagers, adults and older adults living with disability.
Our disability support services in Eltham [https://mindandbodysupport.com.au/disability-support-services-eltham/], the organisation works with NDIS participants - both self-managed and plan-managed - along with their families and support coordinators, to deliver flexible…
Man and Van North London: Your Go-To Moving Solution in North London
North London, London - June 23, 2025 - Looking for a stress-free and efficient moving experience in North London? Look no further than Man and Van North London, the trusted, reliable moving service that's changing the way people approach relocation. Based in the heart of North London at 2 Abbotsbury, the team at Man and Van North London provides affordable, hassle-free moving services designed to fit every need.
Whether you're moving…
Entirewire Electrician North Canton Offers Top-Tier Electrical Services for Nort …
Image: https://www.getnews.info/wp-content/uploads/2024/09/1726505467.png
Entirewire Electrician North Canton provides high-quality electrical services to residential and commercial clients in North Canton, OH. Specializing in electrical panel replacement, repairs, and installations, their team of certified electricians ensures safe, reliable, and efficient solutions, making them a trusted choice for all electrical needs in the local community.
North Canton, OH - Entirewire Electrician North Canton continues to provide exceptional electrical services for residents and businesses in the…
Web Design North: Providing Exceptional Graphic Design Services in North Bay
Web Design North, a leading digital marketing and SEO agency, provides peerless graphic design services in North Bay.
Specific and highly effective digital solutions can help solve the challenges businesses encounter in reaching their target audience. With the combination of these solutions and the expertise of digital professionals, business owners can rest assured that they will make more progress and thrive among their competitors. Web Design North is a dedicated marketing…
Web Design North Offers Digital Marketing Services in North Bay, Canada
Web Design North is a reputable company that provides digital marketing solutions and website development services in Canada.
Web Design North is excited to debut its updated website, showcasing a more modern and user-friendly design. The new site features easy navigation, allowing potential clients to easily browse and learn about the company's services and view their impressive portfolio of work. As a leading web design company, Web Design North understands the…
Web Design North Now Offers North Bay Website Designing Services
Web Design North has successfully worked with businesses of all sizes across North America and internationally.
Web Design North, a leading digital marketing agency in Canada, is proud to announce its expertise in web designing and SEO marketing for businesses in various industries across the country. With a team of experienced professionals, Web Design North has helped numerous clients establish a strong online presence and drive significant traffic to their websites.…
